Asset Management One
SIOX

Asset Management One’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Asset Management One’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-44,737
Closed -$5.12M – 1247
2016
Q3 		$5.12M Sell
44,737
-6,446
-13% -$774K 0.08% 306
2016
Q2 		$5.29M Sell
51,183
-128
-0.2% -$12.8K 0.08% 287
2016
Q1 		$4.7M Buy
51,311
+9,292
+22% +$991K 0.07% 333
2015
Q4 		$6.5M Buy
42,019
+7,955
+23% +$1.04M 0.1% 241
2015
Q3 		$3.33M Buy
34,064
+13,089
+62% +$1.53M 0.05% 446
2015
Q2 		$3.35M Buy
+20,975
New +$3.56M 0.05% 478

Other funds holding SIOX

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
IA
IPL Advisers New York $158M AUM 18.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Asset Management One's SIOX Position: Q4 2016 in Review

Asset Management One sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q4 2016, closing a stake of 44,737 shares — an estimated $5.12M sold.

Asset Management One first reported a position in SIOX in Q2 2015 and held it in 6 quarters. The position peaked at $6.5M in Q4 2015. 101 funds tracked by Wall St. Rank hold SIOX as of Q4 2016.

  • Asset Management One reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • Asset Management One sold 44,737 Sio Gene Therapies Inc. Common Stock shares in Q4 2016, an estimated $5.12M.
  • Asset Management One first reported a position in Sio Gene Therapies Inc. Common Stock in Q2 2015 and held it in 6 quarters.
  • Asset Management One's Sio Gene Therapies Inc. Common Stock position peaked at $6.5M in Q4 2015.
  • 101 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q4 2016.

Based on Asset Management One's 13F filing for Q4 2016, filed 13 Feb 2017.